Taysha Gene Therapies Inc

NASDAQ:TSHA   3:59:48 PM EDT
25.00
+0.01 (+0.04%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Taysha Gene Therapies Inc Stock, NASDAQ:TSHA

3000 Pegasus Park Drive, Suite 1430, Dallas, Texas 75247
United States of America
Phone: +1.214.612.0000
Number of Employees:

Description

Taysha Gene Therapies, Inc.is a patient-centric, clinical-stage gene therapy company, which engages in the development and commercialization of adeno-associated viruses (AAV) based gene therapies for the treatment of monogenic diseases of the central nervous system. It also develops multiple gene therapy platforms which include AAV9 Discovery, Novel Capsid, and AAV Redosing. The company was founded by Steven Gray, Berge Minassian, and R. A. Session II in 2019 and is headquartered in Dallas, TX.